This article describes the epidemiology of mucosal human papillomavirs (HPV) in adults and
children, its mode of transmission and its associated diseases. Over 40 genotypes of HPV …

OBJECTIVE: Vaccination of young women (15–25 years of age) against human
papillomavirus (HPV) has been shown to be very efficacious in preventing the development …

Background Limited data are available describing human papillomavirus (HPV) genotype
distributions in cervical cancer in the United States. Such studies are needed to predict how …

Objective To evaluate the cumulative incidence of cervical intraepithelial neoplasia II or
worse (grade II+) or cervical intraepithelial neoplasia grade III+ after short term persistence …

Determining the causal attribution of human papillomavirus (HPV) genotypes to cervical
disease is important to estimate the effect of HPV vaccination and to establish a type …

The immunogenicity and safety of an HPV-16/18 AS04-adjuvanted vaccine were assessed
in women aged 26–55 years and compared with women aged 15–25 years in a Phase III …

Little is known about the dynamics of human papillomavirus (HPV) infection and subsequent
development of high-grade cervical intraepithelial neoplasia (CIN2/3), particularly in …

目的了解我国西藏自治区妇女宫颈人乳头状瘤病毒(HPV) 感染率和亚型分布及与HPV
感染相关的因素. 方法于2007 年8 月, 采用整群抽样的方法对西藏自治区拉萨, 日喀则和那曲3 …

Human papillomavirus infection in Beijing, People's Republic of China: a population-based
study | British Journal of Cancer Skip to main content Thank you for visiting nature.com. You are …

Persistent infection with human papillomavirus (HPV) is a necessary cause of cervical
cancer, resulting annually in 274,000 deaths worldwide. Two prophylactic HPV vaccines are …